ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.599,57
-0,46%
S&P 500
5.222,68
0,16%
US Dollar vs BRL
5,1568
0,37%
Bitcoin
61.455,14
1,07%
Brent Oil
82,585
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. AMEX
  6. Goldfield Corp (GV)

  7. Goldfield Corp (GV) Notícias

GV

Goldfield (GV)

Goldfield Corp
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AMEX:GV
DataHoraFonteTítuloCódigoCompanhia
24/01/202304:00Business WireGenomic Vision renforce sa direction en accueillant Frédéric Hammel au poste de Directeur des OpérationsAMEX:GVGoldfield Corp
24/01/202304:00Business WireGenomic Vision Strengthens Leadership Team With the Appointment of Frederic Hammel as Chief Operating OfficerAMEX:GVGoldfield Corp
13/01/202313:45Business WireGenomic Vision : Bilan semestriel du Contrat de Liquidité contracté avec CM-CIC SecuritiesAMEX:GVGoldfield Corp
05/01/202303:00Business WireGenomic Vision Announces Successful Beta Testing of FiberSmart®AMEX:GVGoldfield Corp
05/01/202303:00Business WireGenomic Vision annonce la réussite du bêta test de FiberSmart®AMEX:GVGoldfield Corp
29/11/202204:00Business WireGenomic Vision’s Cutting-Edge TeloSizer® Application to be Used in Cancer ResearchAMEX:GVGoldfield Corp
29/11/202204:00Business WireTeloSizer®, application de pointe développée par Genomic Vision, mise au service de la recherche sur le cancerAMEX:GVGoldfield Corp
10/11/202213:45Business WireGenomic Vision : Nombre total d’actions et de droits de voteAMEX:GVGoldfield Corp
07/11/202203:00Business WireGenomic Vision and Cambridge Consultants, Part of Capgemini, Announce the Development of an Innovative Technology Platform for In-depth Genomic AnalysisAMEX:GVGoldfield Corp
07/11/202203:00Business WireGenomic Vision et Cambridge Consultants, filiale de Capgemini, annoncent le développement d'une plateforme technologique innovante dédiée à l'analyse génomiqueAMEX:GVGoldfield Corp
27/10/202213:00Business WireGenomic Vision : Information financière du 3ème trimestre 2022AMEX:GVGoldfield Corp
27/10/202213:00Business WireGenomic Vision: Financial Information for the Third Quarter of 2022AMEX:GVGoldfield Corp
24/10/202202:30Business WireGenomic Vision : communiqué relatif aux changements au sein de la gouvernanceAMEX:GVGoldfield Corp
24/10/202202:30Business WireGenomic Vision: Press Release Regarding Changes in the Company’s GovernanceAMEX:GVGoldfield Corp
29/09/202213:00Business WireGENOMIC VISION : RÉSULTATS SEMESTRIELS 2022AMEX:GVGoldfield Corp
29/09/202213:00Business WireGenomic Vision: First-half 2022 ResultsAMEX:GVGoldfield Corp
06/09/202213:00Business WireGenomic Vision Announces the Issuance of the 1st Tranche of Convertible Notes With Warrants (OCABSA) for €2 Million, as Part of the Financing Line Concluded With Winance for a Maximum Amount of €30 MillionAMEX:GVGoldfield Corp
06/09/202213:00Business WireGenomic Vision annonce le tirage de la 1ère tranche de 2 M€ dans le cadre du programme de financement conclu avec Winance pour un montant maximum de 30 M€AMEX:GVGoldfield Corp
22/07/202213:29Business WireGenomic Vision: Financial Information for the First Half of 2022AMEX:GVGoldfield Corp
22/07/202213:29Business WireGenomic Vision : Information financière du 1er semestre 2022AMEX:GVGoldfield Corp
18/07/202202:00Business WireGENOMIC VISION : Apport complémentaire au contrat de liquidité conclu avec CM-CIC SecuritiesAMEX:GVGoldfield Corp
18/07/202202:00Business WireGenomic Vision: Additional Contribution to the Liquidity Contract Concluded with CM-CIC SecuritiesAMEX:GVGoldfield Corp
13/07/202213:00Business WireGenomic Vision: Changes in the Company’s GovernanceAMEX:GVGoldfield Corp
13/07/202213:00Business WireGenomic Vision : changements au sein de la gouvernanceAMEX:GVGoldfield Corp
27/06/202213:00Business WireGenomic Vision: Report de l’assemblée générale ordinaire des actionnaires du 28 juin 2022AMEX:GVGoldfield Corp
23/06/202213:00Business WireGenomic Vision Obtains the Renewal of the ISO 13485 : 2016 CertificationAMEX:GVGoldfield Corp
23/06/202213:00Business WireGenomic Vision obtient le renouvellement de sa certification ISO 13485 : 2016AMEX:GVGoldfield Corp
16/06/202214:30Business WireGenomic Vision obtient un nouveau brevet pour sa technique de « Caractérisation Physique des télomères » basée sur le peignage moléculaireAMEX:GVGoldfield Corp
16/06/202214:30Business WireGenomic Vision granted a new patent for its “Physical Characterization of Telomeres” technique based on molecular combingAMEX:GVGoldfield Corp
08/06/202213:00Business WireGenomic Vision : Mise à disposition des documents préparatoires et modalités de participation et de vote à l’assemblée générale ordinaire des actionnaires du 28 juin 2022AMEX:GVGoldfield Corp
 Apresentando as notícias mais relevantes sobre:AMEX:GV

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
BHIA3
Grupo Casas Bahia ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
PETZ3
Pet Center Comercio E Pa... ON
BOV
LREN3
LOJAS RENNER ON
BOV
TELB4
TELEBRAS PN
BOV
GUAR3
GUARARAPES ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados